Indication

Disseminated intravascular coagulation

Disseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade. Read more about Disseminated intravascular coagulation

45 drugs 23 manufacturers

Advertisement

Drugs that treat it

Common Disseminated intravascular coagulation therapies.

Showing 28–36 of 45 drugs

Filter & compare in the drug finder →Opens the drug finder with Disseminated intravascular coagulation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Disseminated intravascular coagulation.

Disseminated intravascular coagulation is a complex, acquired hematologic syndrome characterized by systemic, uncontrolled activation of the coagulation cascade.

It typically occurs secondary to severe underlying conditions such as sepsis, trauma, malignancy, or acute obstetric complications.

Pathophysiologically, widespread intravascular fibrin deposition produces microvascular thrombosis, tissue ischemia, and subsequent multiorgan dysfunction.

As the condition progresses, the ongoing consumption of platelets and clotting factors, often compounded by secondary fibrinolysis, results in a paradoxical, life-threatening hemorrhagic state.

Personalize your experience

Follow Disseminated intravascular coagulation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it